CRE is a stock where the most striking tension is not in the lending market — it's in the gap between where the shares trade and where analysts think they should be.
The valuation setup is the standout angle here. Conduit trades at just 0.74x book value and a trailing P/E of 6.7x, both of which sit well below what you would typically expect from a profitable reinsurer. The mean analyst price target is £7.24 — against a close of £4.53 on Tuesday — implying a return potential of roughly 60%. That is an unusually wide gulf for a stock with no active analyst revisions in the data and a next earnings event not until November 6. The 30-day move in earnings yield (EP) has ticked up, and the P/B has edged higher over the same window, but the re-rating has been modest at best. The dividend yield is also meaningful, with a payout of £0.133 per share declared in late July and paid in August — the most recent in a consistent semi-annual series going back to the company's listing.
The lending market adds almost nothing to this week's story. Short interest is negligible: the borrow market shows utilization of just 0.03%, and availability is effectively uncapped — there are more than 35 million shares available to lend against a position that is vanishingly small. Cost to borrow has been drifting lower all month, falling from 0.89% in mid-August to 0.56% now — already a low absolute number, moving lower still. The ORTEX short score of 41.7 is unremarkable. There is no short-side tension here.
Factor scores point to some divergence worth noting. The DTC (days-to-cover) rank is in the 94th percentile and utilization ranks at the 91st — both of which reflect the micro-scale of any short position relative to the stock's liquidity, rather than any crowding. On the other side, the dividend score ranks at the 82nd percentile, and 30-day EPS momentum sits at the 85th — suggesting positive estimate revisions in the near term, even though the 90-day EPS momentum is more subdued at the 46th percentile and the forward earnings growth score is weak at the 27th. The stock earns marks for income and near-term estimate direction; it loses them on growth trajectory and historical earnings surprise, where it ranks at just the 34th percentile.
The ownership base is concentrated and largely institutional. Fidelity International holds just over 10.5% and Víctor Vallejo — listed as an individual holder — holds another 9.9%, making those two names together nearly a fifth of the company. Artemis, Aviva, Janus Henderson, and Aberforth are all names between 4.8% and 5.4%. Lancaster Investment Management trimmed its position by 1.1 million shares as of May, the only meaningful recorded institutional change in the recent data. Third Avenue Management added around 113,000 shares through June. The insider data is stale — the most recent trades date from March, all of which were share awards to the CEO and CFO, with one small round-trip buy-and-sell from an independent director. Nothing there changes the narrative.
The most recent earnings event on July 29 produced a one-day move of just +0.11% and a five-day move of +0.34% — a muted market reaction to what appears to have been an in-line result. Close peer LRE gained 2.1% on the week while PLGO added 2.4%, leaving CRE's flat weekly performance looking marginally soft by comparison. With the next earnings date set for November 6, the immediate catalyst calendar is quiet. What to watch in the coming weeks is whether the valuation discount narrows through price appreciation or whether analyst targets begin to drift lower toward the stock's actual trading level.
See the live data behind this article on ORTEX.
Open CRE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
